Zobrazeno 1 - 10
of 61
pro vyhledávání: '"R. Wageman"'
Affective phenomena permeate group life. When individuals work together in groups, feelings of pride, fear, hope, anger, and anxiety constantly emerge and have a profound influence on group member behavior. The experience and expression of moods and
Autor:
Teagan R. Wall, Brandon J. Henderson, George Voren, Charles R. Wageman, Purnima Deshpande, Bruce N. Cohen, Sharon R. Grady, Michael J. Marks, Daniel Yohannes, Paul J. Kenny, Merouane Bencherif, Henry A. Lester
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
(E)-5-(Pyrimidin-5-yl)-1,2,3,4,7,8-hexahydroazocine (TC299423) is a novel agonist for nicotinic acetylcholine receptors (nAChRs). We examined its efficacy, affinity, and potency for α6β2∗ (α6β2-containing), α4β2∗, and α3β4∗ nAChRs, usin
Externí odkaz:
https://doaj.org/article/fe16dc1017fe4cafa3021cac90dfb168
Autor:
Rell L Parker, Heidi C O'Neill, Beverley M Henley, Charles R Wageman, Ryan M Drenan, Michael J Marks, Julie M Miwa, Sharon R Grady, Henry A Lester
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0188715 (2017)
The α6 nicotinic acetylcholine receptor (nAChR) subunit is an attractive drug target for treating nicotine addiction because it is present at limited sites in the brain including the reward pathway. Lynx1 modulates several nAChR subtypes; lynx1-nACh
Externí odkaz:
https://doaj.org/article/2f56db3f51614a81b5acf01883f73afa
Autor:
Jordan M. Buck, Charles R. Wageman, Jerry A. Stitzel, Heidi C. O'Neill, Valerie S. Knopik, Kelsey N. Sanders
Publikováno v:
Neuropharmacology. 149:66-82
Maternal smoking during pregnancy, a form of developmental nicotine exposure (DNE), is associated with increased nicotine use and neurodevelopmental disorders such as ADHD in children. Here, we characterize the behavioral, rhythmometric, neuropharmac
Autor:
Pauline W. Ondachi, Hernán A. Navarro, Charles W. Luetje, Michael J. Marks, F. Ivy Carroll, Charles R. Wageman, Ana H. Castro, S. Wayne Mascarella, M. Imad Damaj
Publikováno v:
ACS Chemical Neuroscience. 7:1004-1012
In this study, we report the synthesis, nAChR in vitro and in vivo pharmacological properties of 2'-fluoro-(carbamoylpyridinyl)deschloroepibatidine analogues (5, 6a,b, and 7a,b), which are analogues of our lead structure epibatidine. All of the analo
Autor:
Hernán A. Navarro, Asti Jackson, F. Ivy Carroll, S. Wayne Mascarella, Charles W. Luetje, Charles R. Wageman, M. Imad Damaj, Ana H. Castro, Michael J. Marks
Publikováno v:
ACS Chemical Neuroscience. 6:920-926
Pyrido[3,4]homotropane (PHT) is a conformationally rigid, high affinity analogue of nicotine. (+)-PHT was previously shown to be 266 times more potent than (-)-PHT for inhibition of [(3)H]epibatidine binding to nAChRs but had no antinociceptive activ
Autor:
Julie M. Miwa, Ryan M. Drenan, Rell L. Parker, Michael J. Marks, Beverley M. Henley, Charles R. Wageman, Sharon R. Grady, Henry A. Lester, Heidi C. O'Neill
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 12, p e0188715 (2017)
PLoS ONE, Vol 12, Iss 12, p e0188715 (2017)
The α6 nicotinic acetylcholine receptor (nAChR) subunit is an attractive drug target for treating nicotine addiction because it is present at limited sites in the brain including the reward pathway. Lynx1 modulates several nAChR subtypes; lynx1-nACh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f19659dfc8d0928faafc81c9ea8553f9
https://resolver.caltech.edu/CaltechAUTHORS:20171211-155148787
https://resolver.caltech.edu/CaltechAUTHORS:20171211-155148787
Autor:
Jerry A. Stitzel, Sharon R. Grady, Charles R. Wageman, Heidi C. O'Neill, S. E. Sherman, Michael J. Marks
Publikováno v:
Genes Brain Behav
A single nucleotide polymorphism (SNP) in CHRNA5 (rs16969968, change from an aspartic acid [D] to asparagine [N] at position 398 of the human α5 nicotinic acetylcholine receptor subunit) has been associated with increased risk for nicotine dependenc
Autor:
Tracy Lu, Vanessa L. Norman, Lee R. Cavedine, Kayla A. Stehle, Steven M. Garner, Natiya E. Robinson, Alyssa M. Croff, Jesse J. Parry, Victoria V. McBain, Kristin C. Dempsey, Joseph T. Murphy, Charles R. Wageman, Brogan A. Epkins, Alastair J. King
Publikováno v:
Cancer Research. 79:4245-4245
High-throughput, cell-based drug screening platforms are essential to guiding drug discovery programs and can rapidly generate large amounts of pharmacological information about a candidate drug. Drug response data combined with genomic and phenotypi
Autor:
Alastair J. King, Natiya E. Robinson, Kayla A. Stehle, Steven M. Garner, Jesse J. Parry, Vanessa L. Norman, Kristin C. Dempsey, Joseph W. Murphy, Charles R. Wageman, Alyssa M. Croff, Lee R. Cavedine, Tracy Lu, Brogan A. Epkins, Victoria V. McBain
Publikováno v:
Cancer Research. 79:2073-2073
Oncology drugs with clinical utility for the treatment of breast cancer span a wide range of different mechanisms and cancer type profiles. Anti-cancer therapies have come a long way from the early use of broad spectrum, cytotoxic agents, with mechan